Valuation: AngioDynamics, Inc.

Market Cap 631M 544M 515M 467M 876M 60.3B 880M 6.12B 2.35B 30.68B 2.37B 2.32B 96.93B P/E 2027 *
-29x
P/E 2028 * -52.1x
Enterprise Value 631M 544M 515M 467M 876M 60.3B 880M 6.12B 2.35B 30.68B 2.37B 2.32B 96.93B EV / Sales 2027 *
1.87x
EV / Sales 2028 * 1.78x
Free-Float
86.06%
Yield 2027 *
-
Yield 2028 * -
1 day+0.20%
1 week+0.46%
Current month-5.33%
1 month-2.49%
3 months+26.20%
6 months+44.06%
Current year+18.93%
1 week 14.94
Extreme 14.935
15.47
1 month 14.85
Extreme 14.85
16.29
Current year 9.39
Extreme 9.39
16.29
1 year 9.39
Extreme 9.39
16.29
3 years 5.26
Extreme 5.26
16.29
5 years 5.26
Extreme 5.26
32
10 years 5.26
Extreme 5.26
32
Manager TitleAgeSince
Chief Executive Officer 62 31/03/2016
Director of Finance/CFO 51 22/10/2019
Chief Tech/Sci/R&D Officer - 31/12/2016
Director TitleAgeSince
Chairman 65 28/04/2014
Director/Board Member 67 28/01/2007
Director/Board Member 62 31/03/2016
Date Insider Type Main position Quantity % Market Cap. Importance
30/07/26 Sell

General Counsel

-23,370 0.0565%
22/07/26 Exercice

Executive/Senior Manager

40,889 0.0990%
22/07/26 Exercice

General Counsel

27,417 0.0664%
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%+0.46%+43.38%+105.24% 631M
-1.36%-5.89%-23.76%-0.72% 176B
-0.72%-3.41%-3.26%+11.85% 116B
+0.19%-2.83%+6.30%+82.00% 61.36B
-1.15%-7.10%+3.53%+37.10% 49.42B
+0.81%-3.73%-4.81%-32.89% 48.44B
-1.75%-5.54%+8.93%-21.09% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.41% 24.37B
+0.73%-4.68%-10.24%+4.31% 21.57B
Average -0.20%-4.39%+6.29%+19.27% 55.84B
Weighted average by Cap. -0.61%-4.83%-6.16%+10.80%

Financials

2027 *2028 *
Net sales 337M 291M 275M 249M 468M 32.23B 470M 3.27B 1.26B 16.4B 1.27B 1.24B 51.81B 355M 306M 290M 263M 493M 33.93B 495M 3.44B 1.32B 17.26B 1.33B 1.3B 54.55B
Net income -22.3M -19.21M -18.19M -16.49M -30.94M -2.13B -31.09M -216M -83.09M -1.08B -83.75M -81.91M -3.42B -12.67M -10.91M -10.33M -9.37M -17.57M -1.21B -17.66M -123M -47.2M -616M -47.57M -46.53M -1.95B
Net Debt - -
Logo AngioDynamics, Inc.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Employees
632
Date Price Change Volume
11/09/26 US$15.27 +0.20% 341,961
10/09/26 US$15.24 -0.52% 238,746
09/09/26 US$15.32 +0.66% 328,776
08/09/26 US$15.22 +0.13% 432,090
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
15.27USD
Average target price
20.00USD
Spread / Average Target
+30.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANGO Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!